REGULATION OF CLONED GABA RECEPTORS BY PHOSPHORYLATION
通过磷酸化调节克隆的 GABA 受体
基本信息
- 批准号:3084804
- 负责人:
- 金额:$ 7.99万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:1993
- 资助国家:美国
- 起止时间:1993-07-01 至 1998-06-30
- 项目状态:已结题
- 来源:
- 关键词:GABA receptor barbiturates benzodiazepine receptor electrophysiology membrane channels molecular cloning neuropharmacology neurophysiology phosphorylation protein kinase A protein kinase C protein structure function receptor binding single cell analysis site directed mutagenesis transfection voltage /patch clamp voltage gated channel
项目摘要
The long-term goal of this project is to elucidate the role(s) of protein
phosphorylation in the regulation of the gamma-aminobutyric acid (GABA)
receptor/channel complex, or GABAA receptor. This receptor/chloride ion
channel is the primary target of GABA, the major inhibitory neuro-
transmitter of the mammalian brain, and is the site of action of
benzodiazepines and barbiturates used in the treatment of anxiety
disorders and epilepsy. Phosphorylation of the receptor by intracellular
protein kinases may alter the expression, modification and assembly of
the receptor/channel complex, its receptor binding and channel gating
characteristics, and/or its desensitization and degradation. A better
understanding of the regulation of GABAA channel function by protein
kinases may guide the development of new anticonvulsant and anxiolytic
agents and influence the clinical treatment of seizure disorders. The
proposed studies will employ and develop techniques in neurophysiology,
neuropharmacology, and molecular biology to characterize whole cell and
single channel currents generated by cloned GABAA receptors expressed in
cultured cells.
Plasmid constructs containing cDNAs encoding GABAA receptor subunits, and
lacZ (the E. coli beta-galactosidase gene, used as a transfection
marker), will be acutely co-transfected into cultured fibroblast (L929)
cells. After identifying transfected cells with a fluorescent beta-
galactosidase substrate, GABAA currents will be recorded using "whole
cell" and single channel patch clamp recordings to study GABAA receptor
pharmacology. Protein kinase A (catalytic subunit) and protein kinase C
(catalytically active) will be included in the recording pipette solution
and dialyzed or perfused through the electrode into the cell, or onto the
cytoplasmic surface of an "outside-out" patch. GABA, benzodiazepines,
barbiturates and neurosteroids will be applied by pressure ejection from
a nearby pipette, or microperfused in the area of the cell or patch for
rapid application and washout studies. Data will be digitized on-line and
subsequently analyzed by computer programs to determine channel
conductance states and gating kinetics, the kinetics of agonist-dependent
desensitization and agonist-independent "rundown." Site-directed
mutagenesis will be used to alter the primary structure of GABAA receptor
subunits by mutating phosphorylation sites to determine precise
structure/function relationships. Other cell types will be used to
express GABAA receptors in larger quantities for receptor binding
experiments to examine changes in receptor binding kinetics in response
to desensitization or receptor phosphorylation states.
该项目的长期目标是阐明蛋白质的作用
γ-氨基丁酸 (GABA) 调节中的磷酸化
受体/通道复合体,或 GABAA 受体。该受体/氯离子
通道是 GABA 的主要靶标,GABA 是主要的抑制性神经元
哺乳动物大脑的递质,是作用部位
用于治疗焦虑症的苯二氮卓类药物和巴比妥类药物
疾病和癫痫。细胞内受体的磷酸化
蛋白激酶可能会改变表达、修饰和组装
受体/通道复合物、其受体结合和通道门控
特性,和/或其脱敏和降解。更好的
了解蛋白质对 GABAA 通道功能的调节
激酶可能指导新型抗惊厥药和抗焦虑药的开发
剂并影响癫痫病的临床治疗。这
拟议的研究将采用和开发神经生理学技术,
神经药理学和分子生物学来表征全细胞和
由克隆的 GABAA 受体产生的单通道电流
培养的细胞。
含有编码GABAA受体亚基的cDNA的质粒构建体,和
lacZ(大肠杆菌β-半乳糖苷酶基因,用作转染
标记),将被急性共转染到培养的成纤维细胞(L929)中
细胞。用荧光 β- 鉴定转染细胞后
半乳糖苷酶底物,GABAA 电流将使用“全
细胞”和单通道膜片钳记录来研究 GABAA 受体
药理。蛋白激酶 A(催化亚基)和蛋白激酶 C
(催化活性)将包含在记录移液器溶液中
并通过电极透析或灌注到细胞中,或到
“从外到外”斑块的细胞质表面。 GABA、苯二氮卓类药物、
巴比妥类和神经类固醇将通过压力喷射来应用
附近的移液器,或在细胞或补片区域进行微灌注
快速应用和冲洗研究。数据将在线数字化并
随后通过计算机程序进行分析以确定频道
电导态和门控动力学,激动剂依赖性动力学
脱敏和不依赖激动剂的“纲要”。现场定向
诱变将用于改变 GABAA 受体的一级结构
通过突变磷酸化位点来确定精确的亚基
结构/功能关系。其他细胞类型将用于
表达大量 GABAA 受体以进行受体结合
检查受体结合动力学响应变化的实验
脱敏或受体磷酸化状态。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Lazar J Greenfield其他文献
Lazar J Greenfield的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Lazar J Greenfield', 18)}}的其他基金
REGULATION OF CLONED GABA RECEPTORS BY PHOSPHORYLATION
通过磷酸化调节克隆的 GABA 受体
- 批准号:
2259683 - 财政年份:1993
- 资助金额:
$ 7.99万 - 项目类别:
相似海外基金
MOLECULAR MECHANISMS OF BARBITURATES AT GABA-A RECEPTORS
巴比妥类药物在 GABA-A 受体上的分子机制
- 批准号:
6186427 - 财政年份:2000
- 资助金额:
$ 7.99万 - 项目类别:
MOLECULAR MECHANISMS OF BARBITURATES AT GABA-A RECEPTORS
巴比妥类药物在 GABA-A 受体上的分子机制
- 批准号:
2889982 - 财政年份:1999
- 资助金额:
$ 7.99万 - 项目类别:
MOLECULAR MECHANISMS OF BARBITURATES AT GABA-A RECEPTORS
巴比妥类药物在 GABA-A 受体上的分子机制
- 批准号:
2674540 - 财政年份:1998
- 资助金额:
$ 7.99万 - 项目类别:
MOLECULAR MECHANISMS OF BARBITURATES AT GABA-A RECEPTORS
巴比妥类药物在 GABA-A 受体上的分子机制
- 批准号:
2460299 - 财政年份:1997
- 资助金额:
$ 7.99万 - 项目类别:
MOLECULAR MECHANISMS OF BARBITURATES AT GABA-A RECEPTORS
巴比妥类药物在 GABA-A 受体上的分子机制
- 批准号:
2242968 - 财政年份:1997
- 资助金额:
$ 7.99万 - 项目类别:
ACUTE AND CHRONIC BARBITURATES--IN VITRO BIOCHEMISTRY
急性和慢性巴比妥酸盐——体外生物化学
- 批准号:
2118213 - 财政年份:1990
- 资助金额:
$ 7.99万 - 项目类别:














{{item.name}}会员




